Abstract

Lamotrigine 1 mg/mL in SuspendIt Plus

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2023 - Volume 27, Number 4

Page(s): 323

Download in electronic PDF format for $75

Abstract

A formulation for preparing Lamotrigine 1 mg/mL in SuspendIt Plus. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2023 Pg. 323	Lamotrigine 1 mg/mL in SuspendIt Plus Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 223	Lamotrigine 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 148	Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 156	Lamotrigine 25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 502	Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 386-389	Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Author(s): Williams LaVonn A, Fokken Dawn
May/Jun 2020 Pg. 229	Prednisolone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Nov/Dec 2019 Pg. 487	Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 167-174	Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
Jul/Aug 2011 Pg. 302-307	Treating Inner Ear Disorders with Intratympanic Drug Administration Author(s): McElhiney Linda F
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 486	Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 87-89	Attention Deficit Hyperactivity Disorder Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 340	Methylprednisolone 4-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 57	Sodium Citrate 9% Nasal Spray for Olfactory Disorders Author(s): Allen Loyd V Jr